1. Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, Bray F. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin. 2021 May;71(3):209-249. DOI: 10.3322/caac.21660 EDN: MRLXRI
2. Состояние онкологической помощи населению России в 2023 году. Под ред. Каприна А.Д., Старинского В.В., Шахзадовой А.O. М.: МНИОИ им. П.А. Герцена - филиал ФГБУ “НМИЦ радиологии” Минздрава России; 2024, 262 с. Доступно по: https://oncology-association.ru/wp-content/uploads/2024/06/sop-2023-elektronnaya-versiya.pdf Дата обращения: 13.02.2025.
3. Zhang ZH, Su PY, Hao JH, Sun YH. The role of preexisting diabetes mellitus on incidence and mortality of endometrial cancer: a meta-analysis of prospective cohort studies.Int J Gynecol Cancer. 2013 Feb;23(2):294-303. DOI: 10.1097/igc.0b013e31827b8430
4. Lai Y, Sun C. Association of abnormal glucose metabolism and insulin resistance in patients with atypical and typical endometrial cancer. Oncol Lett. 2018 Feb;15(2):2173-2178. DOI: 10.3892/ol.2017.7590 EDN: VERDLE
5. Byrne FL, Martin AR, Kosasih M, Caruana BT, Farrell R. The Role of Hyperglycemia in Endometrial Cancer Pathogenesis. Cancers (Basel). 2020 May 8;12(5):1191. DOI: 10.3390/cancers12051191 EDN: WHBARA
6. Zabuliene L, Kaceniene A, Steponaviciene L, Linkeviciute-Ulinskiene D, Stukas R, Arlauskas R, et al. Risk of Endometrial Cancer in Women with Diabetes: A Population-Based Retrospective Cohort Study. J Clin Med. 2021 Aug 4;10(16):3453. DOI: 10.3390/jcm10163453 EDN: ZFIVEN
7. Constantine GD, Kessler G, Graham S, Goldstein SR. Increased Incidence of Endometrial Cancer Following the Women’s Health Initiative: An Assessment of Risk Factors. J Womens Health (Larchmt). 2019 Feb;28(2):237-243. DOI: 10.1089/jwh.2018.6956
8. Wu D, Hu D, Chen H, Shi G, Fetahu IS, Wu F, et al. Glucose-regulated phosphorylation of TET2 by AMPK reveals a pathway linking diabetes to cancer. Nature. 2018 Jul;559(7715):637-641. DOI: 10.1038/s41586-018-0350-5 EDN: YDWFTH
9. McVicker L, Cardwell CR, Edge L, McCluggage WG, Quinn D, Wylie J, McMenamin ÚC. Survival outcomes in endometrial cancer patients according to diabetes: a systematic review and meta-analysis. BMC Cancer. 2022 Apr 20;22(1):427. DOI: 10.1186/s12885-022-09510-7 EDN: ORTLYS
10. Франциянц Е. М., Бандовкина В. А., Каплиева И. В., Сурикова Е. И., Нескубина И. В., Погорелова Ю. А. и др. Изменение патофизиологии роста опухоли и функциональной активности гипоталамо-гипофизарно-тиреоидной оси у крыс обоего пола с карциномой Герена на фоне гипотиреоза. Южно-Российский онкологический журнал. 2022;3(4):26-39. DOI: 10.37748/2686-9039-2022-3-4-3 EDN: UCXVOA
11. Vollmer G. Endometrial cancer: experimental models useful for studies on molecular aspects of endometrial cancer and carcinogenesis. Endocr Relat Cancer. 2003 Mar;10(1):23-42. DOI: 10.1677/erc.0.0100023 EDN: MEKETF
12. Черкашина Д. В., Лебединский А. С., Петренко Ю. А., Штеменко Н. И., Петренко А. Ю. Торможение роста карциномы Герена у крыс после ведения мезенхимальных стромальных клеток жировой ткани человека и биорегуляторов стволовых и прогениторных клеток. Журнал АМН України. 2010;16(3):492-506.
13. Zhang W, Fan W, Rachagani S, Zhou Z, Lele SM, Batra SK, Garrison JC.Comparative Study of Subcutaneous and Orthotopic Mouse Models of Prostate Cancer: Vascular Perfusion, Vasculature Density, Hypoxic Burden and BB2r-Targeting Efficacy. Sci Rep. 2019 Jul 31;9(1):11117. DOI: 10.1038/s41598-019-47308-z EDN: QONUWN
14. Кадомцев Д. В., Пасечникова Е. А., Голубев В. Г. Золетил-ксилазиновый наркоз в экспериментах у крыс. Международный журнал прикладных и фундаментальных исследований. 2015;5-1:56-57. EDN: UAUPXB
15. Бородин Ю. И., Малыгин М. В., Асташов В. В., Маринкин И. О., Ларионов П. М., Мичурин И. Е. и др. Способ моделирования опухоли тела матки для исследования ее регионарного лимфатического русла. Патент Российской Федерации RU 2220459C1, 27.12.2003.
16. Sidorkiewicz I, Jóźwik M, Niemira M, Krętowski A. Insulin Resistance and Endometrial Cancer: Emerging Role for microRNA. Cancers (Basel). 2020 Sep 8;12(9):2559. DOI: 10.3390/cancers12092559 EDN: ONAFVX
17. Ma J, Yao Z, Ma L, Zhu Q, Zhang J, Li L, Liu C. Glucose metabolism reprogramming in gynecologic malignant tumors. J Cancer. 2024 Mar 17;15(9):2627-2645. DOI: 10.7150/jca.91131 EDN: UVPRHZ
18. Byrne FL, Poon IK, Modesitt SC, Tomsig JL, Chow JD, Healy ME, et al. Metabolic vulnerabilities in endometrial cancer. Cancer Res. 2014 Oct 15;74(20):5832-5845. DOI: 10.1158/0008-5472.can-14-0254 EDN: USJRRN
19. Levin DA, The Cancer Genome Atlas Research Network.Integrated genomic characterization of endometrial carcinoma. Nature. 2013;497(7447):67-73. DOI: 10.1038/nature12113 EDN: RFJQTN
20. Mujammami M, Rafiullah M, Alfadda AA, Akkour K, Alanazi IO, Masood A, et al. Proteomic Analysis of Endometrial Cancer Tissues from Patients with Type 2 Diabetes Mellitus. Life (Basel). 2022 Mar 28;12(4):491. DOI: 10.3390/life12040491 EDN: LQKPPP
21. Shikhlyarova AI, Kit OI, Frantsiyants EM, Kaplieva IV, Zhukova GV, Neskubina IV, et al. Relationship between comorbid pathology and tumor progression. Morphological portrayal of internal organs in modeling the growth of Guerin’s carcinoma under diabetic conditions. Cardiometry. 2022;21:18-26. DOI: 10.18137/cardiometry.2022.21.1826 EDN: ZLMYZC
22. Duzguner S, Turkmen O, Kimyon G, Duzguner IN, Karalok A, Basaran D, et al. Mucinous endometrial cancer: Clinical study of the eleven cases. North Clin Istanb. 2019 Jul 3;7(1):60-64. DOI: 10.14744/nci.2019.17048
23. Ohira S, Tachibana R, Yasaki S, Tsunemi K, Uchiyama N, Ikeda E, Sano K. Mucinous carcinoma originating from uterine adenomyosis: a case report. J Med Case Rep. 2023 Feb 6;17(1):36. DOI: 10.1186/s13256-023-03772-w EDN: JWHLYJ
24. Bragantini E, Angelico G, Disanto MG, Magri E, Maccio L, Barbareschi M. Gastric (gastrointestinal)-type endometrial adenocarcinoma presenting as a solitary endometrial polyp: a case report and literature review on a novel and potentially aggressive endometrial cancer histotype. Pathologica. 2023 Aug;115(4):227-231. DOI: 10.32074/1591-951x-870 EDN: XYEYTM
25. Galic V, Schiavone MB, Herzog TJ, Holcomb K, Lewin SN, Lu YS, Neugut AI, Hershman DL, Wright JD. Prognostic significance of mucinous differentiation of endometrioid adenocarcinoma of the endometrium. Cancer Invest. 2013 Aug;31(7):500-504. DOI: 10.3109/07357907.2013.820321
26. Wong RW, Ralte A, Grondin K, Talia KL, McCluggage WG. Endometrial Gastric (Gastrointestinal)-type Mucinous Lesions: Report of a Series Illustrating the Spectrum of Benign and Malignant Lesions. Am J Surg Pathol. 2020 Mar;44(3):406-419.